Serious side effects (frequency unknown): Shock, anaphylaxis: As shock or anaphylaxis (elevated airway pressure, decreased blood pressure, tachycardia, generalised flushing of skin, etc.) may occur, patients should be observed sufficiently. If any abnormalities are found, administration should be stopped immediately and appropriate treatment should be performed.
Prolonged respiratory depression: Prolonged respiratory depression may occur. In such cases, exercise respiratory control until the spontaneous breathing is restored.
Rhabdomyolysis: Rhabdomyolysis, characterized by muscle pain, weakness, increased CK (CPK), and elevated blood and urine myoglobin, has been reported in similar drugs. In such cases, take appropriate measures such as discontinuing administration immediately.
Bronchospasm: Because bronchospasm may occur, the patient should be carefully monitored. If any abnormalities are observed, discontinue administration and take appropriate measures.
Other side effects: See Table 3.
Click on icon to see table/diagram/image
View ADR Reporting Link
Sign Out